[16:00 CET 26-02] GLOBAL – Pharmaceutical firms operating in emerging markets regions offer huge investment potential for the future, but business models need to be adapted to the local environment and could in turn require new longer-term financing structures, suggests a study conducted by two major European pension funds.
Already a registered user or member? Sign in here
Registration also includes access to